BACKGROUND: High shear force critically regulates platelet adhesion and thrombus formation during ischemic vascular events. To identify genetic factors that influence platelet thrombus formation under high shear stress, we performed a genome-wide association study and confirmatory experiments in human and animal platelets. METHODS AND RESULTS: Closure times in the shear-dependent platelet function analyzer (PFA)-100 were measured on healthy, nondiabetic European Americans (n=125) and blacks (n=116). A genome-wide association (P<5×10(-8)) was identified with 2 single-nucleotide polymorphisms within the SVIL gene (chromosome 10p11.23) in African Americans but not European Americans. Microarray analyses of human platelet RNA demonstrated the presence of SVIL isoform 1 (supervillin) but not muscle-specific isoforms 2 and 3 (archvillin, SmAV). SVIL mRNA levels were associated with SVIL genotypes (P≤0.02) and were inversely correlated with PFA-100 closure times (P<0.04) and platelet volume (P<0.02). Leukocyte-depleted platelets contained abundant levels of the ≈205-kDa supervillin polypeptide. To assess functionality, mice lacking platelet supervillin were generated and back-crossed onto a C57BL/6 background. Compared with controls, murine platelets lacking supervillin were larger by flow cytometry and confocal microscopy and exhibited enhanced platelet thrombus formation under high-shear but not low-shear conditions. CONCLUSIONS: We show for the first time that (1) platelets contain supervillin; (2) platelet thrombus formation in the PFA-100 is associated with human SVIL variants and low SVIL expression; and (3) murine platelets lacking supervillin exhibit enhanced platelet thrombus formation at high shear stress. These data are consistent with an inhibitory role for supervillin in platelet adhesion and arterial thrombosis.
BACKGROUND: High shear force critically regulates platelet adhesion and thrombus formation during ischemic vascular events. To identify genetic factors that influence platelet thrombus formation under high shear stress, we performed a genome-wide association study and confirmatory experiments in human and animal platelets. METHODS AND RESULTS: Closure times in the shear-dependent platelet function analyzer (PFA)-100 were measured on healthy, nondiabetic European Americans (n=125) and blacks (n=116). A genome-wide association (P<5×10(-8)) was identified with 2 single-nucleotide polymorphisms within the SVIL gene (chromosome 10p11.23) in African Americans but not European Americans. Microarray analyses of human platelet RNA demonstrated the presence of SVIL isoform 1 (supervillin) but not muscle-specific isoforms 2 and 3 (archvillin, SmAV). SVIL mRNA levels were associated with SVIL genotypes (P≤0.02) and were inversely correlated with PFA-100 closure times (P<0.04) and platelet volume (P<0.02). Leukocyte-depleted platelets contained abundant levels of the ≈205-kDa supervillin polypeptide. To assess functionality, mice lacking platelet supervillin were generated and back-crossed onto a C57BL/6 background. Compared with controls, murine platelets lacking supervillin were larger by flow cytometry and confocal microscopy and exhibited enhanced platelet thrombus formation under high-shear but not low-shear conditions. CONCLUSIONS: We show for the first time that (1) platelets contain supervillin; (2) platelet thrombus formation in the PFA-100 is associated with humanSVIL variants and low SVIL expression; and (3) murine platelets lacking supervillin exhibit enhanced platelet thrombus formation at high shear stress. These data are consistent with an inhibitory role for supervillin in platelet adhesion and arterial thrombosis.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Shahrokh Falati; Sonali Patil; Peter L Gross; Michelle Stapleton; Glenn Merrill-Skoloff; Natasha E Barrett; Katherine L Pixton; Harmut Weiler; Brian Cooley; Debra K Newman; Peter J Newman; Barbara C Furie; Bruce Furie; Jonathan M Gibbins Journal: Blood Date: 2005-09-15 Impact factor: 22.113
Authors: Martin Frossard; Ingrid Fuchs; Judith M Leitner; Kety Hsieh; Marianne Vlcek; Heidrun Losert; Hans Domanovits; Wolfgang Schreiber; Anton N Laggner; Bernd Jilma Journal: Circulation Date: 2004-08-16 Impact factor: 29.690
Authors: A A Kondkar; M S Bray; S M Leal; S Nagalla; D J Liu; Y Jin; J F Dong; Q Ren; S W Whiteheart; C Shaw; P F Bray Journal: J Thromb Haemost Date: 2009-11-23 Impact factor: 5.824
Authors: John D Eicher; Luting Xue; Yoav Ben-Shlomo; Andrew D Beswick; Andrew D Johnson Journal: J Thromb Thrombolysis Date: 2016-02 Impact factor: 2.300
Authors: John D Eicher; Ming-Huei Chen; Achilleas N Pitsillides; Honghuang Lin; Narayanan Veeraraghavan; Jennifer A Brody; Ginger A Metcalf; Donna M Muzny; Richard A Gibbs; Diane M Becker; Lewis C Becker; Nauder Faraday; Rasika A Mathias; Lisa R Yanek; Eric Boerwinkle; L Adrienne Cupples; Andrew D Johnson Journal: Thromb Haemost Date: 2017-03-16 Impact factor: 5.249
Authors: Janelle M Spinazzola; Tara C Smith; Min Liu; Elizabeth J Luna; Elisabeth R Barton Journal: Hum Mol Genet Date: 2015-01-20 Impact factor: 6.150
Authors: Stanislav O Fedechkin; Jacob Brockerman; Elizabeth J Luna; Michail Yu Lobanov; Oxana V Galzitskaya; Serge L Smirnov Journal: J Biomol Struct Dyn Date: 2012-10-17
Authors: Paul F Bray; Steven E McKenzie; Leonard C Edelstein; Srikanth Nagalla; Kathleen Delgrosso; Adam Ertel; Joan Kupper; Yi Jing; Eric Londin; Phillipe Loher; Huang-Wen Chen; Paolo Fortina; Isidore Rigoutsos Journal: BMC Genomics Date: 2013-01-16 Impact factor: 3.969